Camber Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $184M | Sell |
|
|||||
|
2020
Q3 | $149M | Sell |
|
|||||
|
2020
Q2 | $157M | Sell |
|
|||||
|
2020
Q1 | $148M | Buy |
|
|||||
|
2019
Q4 | $94.6M | Buy |
|
|||||
|
2019
Q3 | $83.2M | Buy |
|
|||||
|
2019
Q2 | $52.4M | Sell |
|
|||||
|
2019
Q1 | $81.1M | Hold |
|
|||||
|
2018
Q4 | $58.4M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $24.3M | Buy |
|